P
Pejman Rohani
Researcher at University of Georgia
Publications - 222
Citations - 15148
Pejman Rohani is an academic researcher from University of Georgia. The author has contributed to research in topics: Population & Internal medicine. The author has an hindex of 52, co-authored 192 publications receiving 13386 citations. Previous affiliations of Pejman Rohani include Boston Children's Hospital & Sea Mammal Research Unit.
Papers
More filters
Journal ArticleDOI
Implementation and adherence of routine pertussis vaccination (DTP) in a low-resource urban birth cohort
Christian E. Gunning,Lawrence Mwananyanda,William B. MacLeod,Magdalene Mwale,Donald M. Thea,Rachel Pieciak,Pejman Rohani,Christopher J. Gill +7 more
TL;DR: In this article, a longitudinal analysis of the directly observed administration of a three-dose primary vaccination series to infants in a low-resource community in Lusaka, Zambia, was provided.
Journal ArticleDOI
Commentary: resolving pertussis resurgence and vaccine immunity using mathematical transmission models.
TL;DR: It is proposed that mathematical transmission models play an essential role in helping to interpret the data and in closing knowledge gaps in pertussis epidemiology and that recent advances in statistical inference methods now allow to estimate key parameters, such as the nature and duration of vaccinal immunity, which have to date been difficult to quantify.
Journal ArticleDOI
Anomalous influenza seasonality in the United States and the emergence of novel influenza B viruses
Rebecca K. Borchering,Christian E. Gunning,Deven V. Gokhale,K. Bodie Weedop,Arash Saeidpour,Tobias S. Brett,Pejman Rohani +6 more
TL;DR: The 2019/2020 influenza season in the United States began earlier than any season since the 2009 H1N1 pandemic, with an increase in influenza-like illnesses observed as early as August.
Journal ArticleDOI
Evaluation of Clarithromycin and Metronidazole Resistance of Helicobacter Pylori Infection in Symptomatic Iranian Children
Mohammad Haghighi,Naghi Dara,Roxana Mansour Ghanaie,Leila Azimi,Amirhossein Hosseini,Saleheh Tajalli,Mahmoud Hajipour,Aliakbar Sayyari,Farid Imanzadeh,Katayoun Khatami,Pejman Rohani,Beheshteh Olang +11 more
TL;DR: It is better to check microbial resistance by culture and antibiogram for the antibiotic regimen of the first and second line of H. pylori treatment in children.
Journal ArticleDOI
Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology.
TL;DR: According to the evidence, SARS-CoV-2 infection is milder in children and may present different clinical symptoms from adults, and Diagnosis, treatment, and isolation of children are the most effective ways to control the expansion of the COVID-19 pandemic.